Eugia SEZ Pvt Ltd's injectable facility gets EIR from USFDA

The U.S. Food and Drug Administration (FDA) had conducted an inspection at the injectable facility of Eugia SEZ Pvt. Ltd. (a 100% step-down subsidiary of Aurobindo Pharma Ltd.), situated at Polepally Village, Jadcherla Mandal, Mahaboobnagar District, Telangana, from February 19 to February 29, 2024.

The Unit has now received Establishment Inspection Report classifying the facility as "Voluntary Action Indicated" ("VAI")

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1200.50 as compared to the previous close of Rs. 1218.50. The total number of shares traded during the day was 24572 in over 2410 trades.

The stock hit an intraday high of Rs. 1220.05 and intraday low of 1193.75. The net turnover during the day was Rs. 29606803.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 EugiaSEZ EIR USFDA VAI